Comparison of Propofol and Dexmedetomidine to Treat Hyperactive and Mixed ICU Delirium - the Basel ProDex Randomized Trial

Trial Profile

Comparison of Propofol and Dexmedetomidine to Treat Hyperactive and Mixed ICU Delirium - the Basel ProDex Randomized Trial

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 10 Apr 2018

At a glance

  • Drugs Dexmedetomidine (Primary) ; Propofol
  • Indications Delirium
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Apr 2018 Planned initiation date changed from 1 Mar 2018 to 1 Nov 2018.
    • 02 Feb 2018 Planned initiation date changed from 1 Jan 2018 to 1 Mar 2018.
    • 08 Jan 2018 Planned End Date changed from 1 Jan 2020 to 1 Jan 2021.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top